BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31912484)

  • 1. Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients.
    Aparicio T; Henriques J; Manfredi S; Tougeron D; Bouché O; Pezet D; Piessen G; Coriat R; Zaanan A; Legoux JL; Terrebone E; Pocard M; Gornet JM; Lecomte T; Lombard-Bohas C; Perrier H; Lecaille C; Lavau-Denes S; Vernerey D; Afchain P;
    Int J Cancer; 2020 Aug; 147(4):967-977. PubMed ID: 31912484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
    Huffman BM; Jin Z; Yadav S; Patel S; Nagorney DM; Truty MJ; McWilliams RR; Halfdanarson TR; Mahipal A
    Clin Colorectal Cancer; 2019 Sep; 18(3):218-225. PubMed ID: 31178274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small bowel adenocarcinoma as a complication of celiac disease: clinical and diagnostic features.
    Caio G; Volta U; Ursini F; Manfredini R; De Giorgio R
    BMC Gastroenterol; 2019 Mar; 19(1):45. PubMed ID: 30917787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.
    Aydin D; Sendur MA; Kefeli U; Unal OU; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Ustaalioglu BB; Uysal M; Esbag O; Yazilitas D; Tanrıverdi O; Bilici A; Arpaci E; Berk V; Yetisyigit T; Ozdemir NY; Oztop I; Alacacioglu A; Aydin O; Ozcelik M; Yildirim E; Dinc N; Gumus M
    Clin Colorectal Cancer; 2017 Sep; 16(3):220-227. PubMed ID: 27670893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study.
    Rompteaux P; Gagnière J; Gornet JM; Coriat R; Baumgaertner I; Lecomte T; Afchain P; Zaanan A; Pocard M; Bachet JB; Bonichon-Lamichhane N; Bouché O; Faucheron JL; Forestier J; Lecaille C; Manfredi S; Tougeron D; Terrebonne E; Chehimi M; Villing AL; Sarda C; Legoux JL; Benamouzig R; Aparicio T
    Eur J Surg Oncol; 2019 Mar; 45(3):331-335. PubMed ID: 30501999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and treatment outcomes in patients with non-ampullary small bowel adenocarcinoma: Long-term analysis.
    Tian J; Liu J; Guo C; Yang X; Yang Y; Gou H; Qiu M; Cao D
    Medicine (Baltimore); 2019 Apr; 98(17):e15381. PubMed ID: 31027129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of surgery and chemotherapy for stage IV small bowel adenocarcinoma: A population-based analysis using Surveillance, Epidemiology, and End Result Program database.
    Liu T; Wu Y; Jiang T
    Cancer Med; 2020 Sep; 9(18):6638-6645. PubMed ID: 32750232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators.
    Moon YW; Rha SY; Shin SJ; Chang H; Shim HS; Roh JK
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):387-94. PubMed ID: 19760196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small bowel adenocarcinoma].
    Zaanan A; Afchain P; Carrere N; Aparicio T
    Gastroenterol Clin Biol; 2010; 34(6-7):371-9. PubMed ID: 20537487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Bowel Adenocarcinoma: 10-Year Experience in a Cancer Center-The Ottawa Hospital (TOH).
    Alfagih A; Alrehaili M; Asmis T
    Curr Oncol; 2022 Oct; 29(10):7439-7449. PubMed ID: 36290862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence and Survival Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Small Bowel Adenocarcinoma.
    Saxena A; Valle SJ; Liauw W; Morris DL
    Anticancer Res; 2017 Oct; 37(10):5737-5742. PubMed ID: 28982894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized four-category staging for predicting prognosis in patients with small bowel Adenocarcinoma: an international development and validation study.
    Dai ZH; Wang QW; Zhang QW; Yan XL; Aparicio T; Zhou YY; Wang H; Zhang CH; Zaanan A; Afchain P; Zhang Y; Chen HM; Gao YJ; Ge ZZ
    EBioMedicine; 2020 Oct; 60():102979. PubMed ID: 32980692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history and prognostic factors for localised small bowel adenocarcinoma.
    Colina A; Hwang H; Wang H; Katz MHG; Sun R; Lee JE; Thomas J; Tzeng CW; Wolff RA; Raghav K; Overman MJ
    ESMO Open; 2020 Nov; 5(6):e000960. PubMed ID: 33188051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study.
    Sakae H; Kanzaki H; Nasu J; Akimoto Y; Matsueda K; Yoshioka M; Nakagawa M; Hori S; Inoue M; Inaba T; Imagawa A; Takatani M; Takenaka R; Suzuki S; Fujiwara T; Okada H
    Br J Cancer; 2017 Nov; 117(11):1607-1613. PubMed ID: 28982111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
    Aparicio T; Svrcek M; Henriques J; Afchain P; Lièvre A; Tougeron D; Gagniere J; Terrebonne E; Piessen G; Legoux JL; Lecaille C; Pocard M; Gornet JM; Zaanan A; Lavau-Denes S; Lecomte T; Deutsch D; Vernerey D; Puig PL
    Int J Cancer; 2021 Apr; 148(7):1731-1742. PubMed ID: 33186471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors.
    Abrahams NA; Halverson A; Fazio VW; Rybicki LA; Goldblum JR
    Dis Colon Rectum; 2002 Nov; 45(11):1496-502. PubMed ID: 12432298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes of Small Bowel Adenocarcinoma.
    Akce M; Jiang R; Zakka K; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
    Clin Colorectal Cancer; 2019 Dec; 18(4):257-268. PubMed ID: 31606297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).
    Aydin D; Sendur MA; Kefeli U; Umut Unal O; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Bala Ustaalioglu B; Sener Dede D; Esbag O; Inal A; Bilir C; Bilici A; Harputlu H; Berk V; Sevinc A; Yildirim Ozdemir N; Yildirim E; Sonkaya A; Ali Ustaoglu M; Gumus M
    J BUON; 2016; 21(5):1242-1249. PubMed ID: 27837629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience.
    Khan K; Peckitt C; Sclafani F; Watkins D; Rao S; Starling N; Jain V; Trivedi S; Stanway S; Cunningham D; Chau I
    BMC Cancer; 2015 Jan; 15():15. PubMed ID: 25603878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.